Detection of SARS-CoV-2 with RAPID: A prospective cohort study

Detection of SARS-CoV-2 with RAPID: A prospective cohort study

Summary: COVID-19 has killed over 6 million people worldwide. Currently available methods to detect SARS-CoV-2 are limited by their cost and need for multistep sample preparation and trained personnel. Therefore, there is an urgent need to develop fast, inexpensive, and scalable point-of-care diagno...

Full description

Bibliographic Details
Main Authors:	Marcelo D.T. Torres, Lucas F. de Lima, André L. Ferreira, William R. de Araujo, Paul Callahan, Antonio Dávila, Jr., Benjamin S. Abella, Cesar de la Fuente-Nunez
Format:	Article
Language:	English
Published:	Elsevier 2022-04-01
Series:	iScience
Subjects:	Medicine Medical laboratory technology Sensor Virology Bioelectronics
Online Access:	http://www.sciencedirect.com/science/article/pii/S258900422200325X

Similar Items

A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19
by: Friederike Krempe, et al.
Published: (2021-10-01)

Building a bioelectronic medicine movement 2019: insights from leaders in industry, academia, and research
by: Alliance for Advancing Bioelectronic Medicine
Published: (2020-01-01)

Introductory bioelectronics : for engineers and physical scientists /
by: 454029 Pethig, Ronald, et al.
Published: (2013)

Bioelectronics and Medical Devices /
by: Pal, Kunal, editor 648712, et al.
Published: (2019)

Comparison of automated nucleic acid extraction methods for the detection of cytomegalovirus DNA in fluids and tissues
by: Jesse J. Waggoner, et al.
Published: (2014-04-01)

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
by: Maya Imbrechts, et al.
Published: (2022-08-01)

An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
by: Naveenchandra Suryadevara, et al.
Published: (2022-06-01)

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2
by: Praveen Neeli, et al.
Published: (2023-07-01)

Mutating novel interaction sites in NRP1 reduces SARS-CoV-2 spike protein internalization
by: Debjani Pal, et al.
Published: (2023-04-01)

Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea
by: Atanas V. Demirev, et al.
Published: (2023-09-01)

The effect of the delta SARS-CoV-2 variant on maternal infection and pregnancy
by: Athina Samara, et al.
Published: (2022-05-01)

Smart Janus textiles for biofluid management in wearable applications
by: Xiangnan Li, et al.
Published: (2024-03-01)

Enzymatic biofuel cell: A potential power source for self-sustained smart textiles
by: Jingsheng Cai, et al.
Published: (2024-02-01)

A novel 3D bioprinted flexible and biocompatible hydrogel bioelectronic platform
by: Agarwala, Shweta, et al.
Published: (2018)

Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster
by: Pai Peng, et al.
Published: (2022-11-01)

Molecular identification of virulence genes in laboratory strains streptococcus pneumoniae / Yuhaniz Atiqah Nor Azlan
by: Nor Azlan, Yuhaniz Atiqah
Published: (2015)

SARS-CoV-2-related pangolin coronavirus exhibits similar infection characteristics to SARS-CoV-2 and direct contact transmissibility in hamsters
by: Zhendong Guo, et al.
Published: (2022-06-01)

Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis
by: Nilesh Kumar, et al.
Published: (2020-09-01)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
by: Jun-Gyu Park, et al.
Published: (2021-09-01)

Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance
by: Patrick J. Lenehan, et al.
Published: (2021-07-01)

Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses
by: Arinjay Banerjee, et al.
Published: (2021-05-01)

Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
by: Roberta Marzi, et al.
Published: (2023-01-01)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
by: Yannic C. Bartsch, et al.
Published: (2023-05-01)

Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
by: Elena Mitsi, et al.
Published: (2022-04-01)

SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19
by: Sophie Martin, et al.
Published: (2021-10-01)

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
by: Xingyue An, et al.
Published: (2021-09-01)

Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site
by: Javier A. Jaimes, et al.
Published: (2020-06-01)

Two-years antibody responses following SARS-CoV-2 infection in humans: A study protocol
by: Arguni, Eggi, et al.
Published: (2022)

The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro
by: Markus J. Lehtinen, et al.
Published: (2022-06-01)

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
by: Puthupparampil V. Scaria, et al.
Published: (2022-08-01)

Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
by: Kim M. Stegmann, et al.
Published: (2022-05-01)

Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
by: Kim R. Chiok, et al.
Published: (2023-05-01)

6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro
by: Caleb D. Swaim, et al.
Published: (2021-10-01)

Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa
by: Olayinka Sunday Okoh, et al.
Published: (2022-03-01)

CLN7/MFSD8 may be an important factor for SARS-CoV-2 cell entry
by: Elena-Sofia Heinl, et al.
Published: (2022-10-01)

SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
by: Sarah E. Cummings, et al.
Published: (2024-01-01)

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
by: Jakob Kreye, et al.
Published: (2023-04-01)

HLA-DP diversity is associated with improved response to SARS-Cov-2 vaccine in hematopoietic stem cell transplant recipients
by: Juliette Villemonteix, et al.
Published: (2023-05-01)

Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
by: Shinya Yamamoto, et al.
Published: (2023-07-01)

Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model
by: Takuya Tada, et al.
Published: (2023-02-01)